The nicotinic acetylcholine receptor a1 (nAChRa1) was investigated as a potential proinflammatory molecule in the kidney, given a recent report that it is an alternative urokinase plasminogen activator (uPA) receptor, in addition to the classical receptor uPAR. Two animal models and in vitro monocyte studies were involved: (1) In an ApoE À/À mouse model of chronic kidney disease, glomerular-resident cells and monocytes/macrophages were identified as the primary cell types that express nAChRa1 during hypercholesterolemia/uninephrectomy-induced nephropathy. Silencing of the nAChRa1 gene for 4 months (6 months on Western diet) prevented the increases in renal monocyte chemoattractant protein-1 and osteopontin expression levels and F4/80 þ macrophage infiltration compared with the nonsilenced mice. These changes were associated with significantly reduced transforming growth factor-b1 mRNA (50% decrease) and a smooth muscle actin-positive (aSMA þ ) myofibroblasts (90% decrease), better glomerular and tubular basement membranes (GBM/TBM) preservation (threefold less disintegration), and better renal function preservation (serum creatinine 40% lower) in the nAChRa1-silenced mice. The nAChRa1 silencing was also associated with significantly reduced renal tissue calcium deposition (78% decrease) and calpain-1 (but not calpain-2) activation (70% decrease). (2) The nAChRa1 was expressed in vitro by mouse monocyte cell line WEHI-274.1. The silencing of nAChRa1 significantly reduced both calpain-1 and -2 activities, and reduced the degradation of the calpain substrate talin. (3) To further explore the role of calpain-1 activity in hypercholesterolemic nephropathy, disease severities were compared in CAST À/À ApoE À/À (calpain overactive) mice and ApoE À/À mice fed with Western diet for 10 months (n ¼ 12). Macrophages were the main cell type of renal calpain-1 production in the model. The number of renal F4/80 þ macrophages was 10-fold higher in the CAST À/À ApoE À/À mice (Po0.05), and was associated with a significantly higher level of aSMA þ cells, increased GBM/TBM destruction, and higher serum creatinine levels. Our studies suggest that the receptor nAChRa1 is an important regulator of calpain-1 activation and inflammation in the chronic hypercholesterolemic nephropathy. This new proinflammatory pathway may also be relevant to other disorders beyond hyperlipidemic nephropathy.
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The nicotinic acetylcholine receptor a1 (nAChRa1) was investigated as a potential proinflammatory molecule in the kidney, given a recent report that it is an alternative urokinase plasminogen activator (uPA) receptor, in addition to the classical receptor uPAR. Two animal models and in vitro monocyte studies were involved: (1) In an ApoE À/À mouse model of chronic kidney disease, glomerular-resident cells and monocytes/macrophages were identified as the primary cell types that express nAChRa1 during hypercholesterolemia/uninephrectomy-induced nephropathy. Silencing of the nAChRa1 gene for 4 months (6 months on Western diet) prevented the increases in renal monocyte chemoattractant protein-1 and osteopontin expression levels and F4/80 þ macrophage infiltration compared with the nonsilenced mice. These changes were associated with significantly reduced transforming growth factor-b1 mRNA (50% decrease) and a smooth muscle actin-positive (aSMA þ ) myofibroblasts (90% decrease), better glomerular and tubular basement membranes (GBM/TBM) preservation (threefold less disintegration), and better renal function preservation (serum creatinine 40% lower) in the nAChRa1-silenced mice. The nAChRa1 silencing was also associated with significantly reduced renal tissue calcium deposition (78% decrease) and calpain-1 (but not calpain-2) activation (70% decrease). ( 2) The nAChRa1 was expressed in vitro by mouse monocyte cell line WEHI-274.1. The silencing of nAChRa1 significantly reduced both calpain-1 and -2 activities, and reduced the degradation of the calpain substrate talin. (3) To further explore the role of calpain-1 activity in hypercholesterolemic nephropathy, disease severities were compared in CAST À/À ApoE À/À (calpain overactive) mice and ApoE À/À mice fed with Western diet for 10 months (n ¼ 12). Macrophages were the main cell type of renal calpain-1 production in the model. The number of renal F4/80 þ macrophages was 10-fold higher in the CAST À/À ApoE À/À mice (Po0.05), and was associated with a significantly higher level of aSMA þ cells, increased GBM/TBM destruction, and higher serum creatinine levels. Our studies suggest that the receptor nAChRa1 is an important regulator of calpain-1 activation and inflammation in the chronic hypercholesterolemic nephropathy. This new proinflammatory pathway may also be relevant to other disorders beyond hyperlipidemic nephropathy. The prevalence of overweight and obese individuals has increased rapidly within the past two decades. 1, 2 Subsequently, a greater number of individuals are at risk of developing hypertension, atherosclerosis, coronary artery disease, diabetes, lipoprotein abnormalities, and other organ dysfunction. 3 In addition, recent literature has shown that chronic hyperlipidemia, especially hypercholesterolemia, has lipotoxic effects in the kidney, which lead to renal mesangial and epithelial cell injury, and subsequent fibrosis through a complex inflammatory pathway. [4] [5] [6] The hallmark of hyperlipidemic chronic kidney disease (CKD) is a macrophage dominated inflammatory response (foam cell) that ultimately progresses to glomerulosclerosis. This process may be associated with mesangial expansion, prominent mesangiolysis, capillary microaneurysms, and finally sclerosis. 7 The molecular mechanisms that mediate this series of pathological events in the hyperlipidemic CKD remains poorly understood. Urokinase plasminogen activator (uPA) is a growth factorlike protein, which is produced in large quantities by the kidney. Furthermore, uPA and its classical receptor uPAR have been implicated in various inflammatory-fibrotic disorders, including CKD. 8 Evidence suggests that the uPA/uPAR system regulates cellular responses during inflammation, angiogenesis, wound healing, and tumor metastasis. [9] [10] [11] [12] [13] The muscle-type nicotinic acetylcholine receptor a1 (nAChRa1) has recently been identified as an alternative urokinase receptor. We previously reported that in a mouse obstructive uropathy model of CKD, the nAChRa1 expression is upregulated on interstitial fibroblasts during fibrogenesis. Silencing of the nAChRa1 gene led to significantly fewer interstitial a smooth muscle actin-positive (aSMA þ ) interstitial myofibroblasts, fewer proliferating fibroblasts, better preserved tubular cells, and reduced overall fibrosis severity.
14 This study investigates whether nAChRa1 has a similar protective role in hyperlipidemia-associated CKD.
The activated nAChRa1 also functions as a ligand-gated ion channel, known to mediate signal transduction at the neuromuscular junction. 15 In addition to muscle cells, the muscle-type nAChRa1 is also expressed in vascular endothelium, macrophages, mesangial cells, and fibroblasts. 14, 15 Currently, there exist two known endogenous nAChRa1 ligands: acetylcholine and uPA. On ligation, the receptor changes its conformation and becomes permeable to both calcium and sodium ions. Our previous studies show that on uPA ligation, the muscle-type nAChRa1 initiates intracellular signaling by functioning as a calcium channel. Although specific downstream signaling pathways remain to be delineated, it is believed that calpains, a class of cytosolic calcium-dependent cysteine proteases, may be involved. 16, 17 Recent studies suggest that calpain-1 mediates the inflammatory response by having a role in inflammatory cell migration and chemotaxis, as well as in the expression of proinflammatory cytokines and adhesion molecules. [18] [19] [20] Although it has not yet been studied in any detail in CKD, increased calpain activity has been reported in experimental kidney disease models and is thought to be detrimental in immunity-mediated acute glomerulonephritis. 17 This study was designed to determine whether calpain-1 activation is regulated by nAChRa1 in vivo and in vitro, and to test the hypothesis that the nAChRa1-calpain-1 axis participates in the pathogenesis of hypercholesterolemiainduced renal inflammation and fibrosis. Our findings indicate that the in vivo functional knockdown of nAChRa1 significantly attenuates calpain-1 activity and renal inflammation in an ApoE À/À mouse model of hypercholesterolemic CKD. Data from monocyte cultures further validate that the nAChRa1 is an important regulator for calpain activation. Furthermore, overactivation of calpain-1 in mice due to the absence of its endogenous inhibitor calpastatin exacerbates hypercholesterolemic nephropathy.
MATERIALS AND METHODS Antibodies and cDNA Reagents
Antibodies used in this study and their sources are rat monoclonal antibody to nAChRa1 subunit (Covance, Berkeley, CA, USA); goat polyclonal antibody to nAChRa1, antibodies to monocyte chemoattractant protein-1 (MCP-1), and osteopontin (OPN; Santa Cruz Biotechnology, Santa Cruz, CA, USA); rat monoclonal antibodies to F4/80, CD11b (Serotec, Oxford, UK); EPO horseradish peroxidaseconjugated monoclonal antibody to aSMA (Dako Corp., Carpinteria, CA, USA); fluorescein isothiocyanate (FITC)-conjugated monoclonal antibody to b-actin, antibodies to calpain-1 (clone 15C10 and rabbit polyclone), monoclonal anti-talin antibody (clone 8d4) (Sigma-Aldrich, St Louis, MO, USA); and goat antibody to type IV collagen (Southern Biotechnology Associates, Birmingham, AL, USA). The cDNA reagents used in the in vitro and in vivo RNA interference (RNAi) studies are the nAChRa1-siRNA-expressing construct psir2 and the matched scramble RNA-expressing construct pscr that we previously described.
14 Cell Culture and nAChRa1-RNAi Experiments WEHI-274.1 cells, a mouse monocyte cell line that expresses CD11b antigen, 21 were used as an in vitro model to determine whether monocytes/macrophages express nAChRa1, and to investigate the regulatory action of nAChRa1 on calpain-1 activation. Cells were routinely cultured at 371C with 5% CO2 in complete Dulbecco's modified Eagle's medium (DMEM/F12, 1:1, pH 7.35-7.45) (Mediatech, Manassas, VA, USA) containing 10% fetal bovine serum (vol/vol) and 0.05 mM 2-mercaptoethanol. For the nAChRa1-RNAi experiments, the psir2 and pscr cDNAs were transiently transfected into the WEHI-274.1 cell cultures in 12-well plates using siPORT XP-1 transfection agent for 24 h (Ambion, Austin, TX, USA) according to the manufacturer's instruction. The cells were then cultivated in the complete DMEM/F12 plus G418 (200 mg/ml) for an additional 24 h (n ¼ 6 per group, two independent experiments). Cells were harvested by dislodging adherent cells by scraping and collecting floating cells into centrifuge tubes. Following centrifugation at 800 r.p.m. for 5 min, 10 ml of cell pellet diluted in normal saline from each well was used to make cell smears for evaluating nAChRa1 expression by immunocytochemistry. The remaining cell pellets were lysed in sample buffer (100 mM Tris (pH6.8), 20% glycerol, 0.75% b-mercaptoethanol, 10 mM EDTA). Calpain activity was evaluated using the cell lysate by a previously depicted casein zymography method 22 and talin-a calpain substratewestern blot analyses.
Animals and Experimental Design
In vivo nAChRa1-RNAi study in ApoE À/À mice ApoE-deficient mice were used in this study as the model of hyperlipidemic nephropathy, because renal injury in these mice has been well characterized previously. 7 Female ApoE À/À nAChRa1 and macrophage calpain-1 activation G Zhang et al mice on a C57BL/6J background were purchased from the Jackson Laboratories (Bar Harbor, ME, USA), and were fed with Western-type diet containing 21% fat and 0.15% cholesterol (TD88137; Harlan-Teklad Laboratories, Indianapolis, IN, USA) beginning at 8 weeks of age. To functionally knockdown renal nAChRa1 expression, RNAi intervention started from 2 months on the Western diet. Naked plasmid DNA that expresses hairpin nAChRa1-siRNA (psir2) or scramble RNA (pscr) was administered (n ¼ 12 per group) using an aorta-renal hydrodynamic protocol modified from a previous publication. 23 Briefly, a surgery was performed under general anesthesia to fully expose abdominal aorta and left renal artery. The distal end of left renal artery was ligated and a loose thread loop was placed in the proximal end. Aortic blood flow was temporarily blocked at points above and below the two renal arteries. Following an instant injection of 100 mg DNA (psir2 or pscr) in 200 ml normal saline, the preset left renal artery loop was immediately tied, and the upper and lower aortic blocking points were subsequently released. The left kidney was removed and tissues stored for subsequent studies (as a baseline disease control for the mice). 24 After the surgery, the mice were maintained on the Western diet for an additional 4 months before being killed by exsanguination under general anesthesia. The right kidney and serum samples were collected and stored for further analyses.
Calpain overactivity study in CAST À/À ApoE À/À mice versus ApoE À/À mice To investigate the role of calpain activation as a downstream effecter of the nAChRa1 pathway in the progression of hyperlipidemic kidney injury, a study was designed to compare the degree of kidney injury in ApoE À/À mice and in ApoE À/À mice lacking calpastatin. The calpain activity was manipulated using calpastatin (the only endogenous calpain inhibitor) gene knockout (CAST À/À ) mice cross-bred onto the ApoE À/À mice. Both strains were on an identical genetic background (96.3-98.2% C57BL/6J, 1.9-3.8% 129/Sv). The resulting heterozygote mice in the first generation were intercrossed. After five generations of mating, double homozygote (CAST À/À ApoE À/À or DK) breeding pairs were obtained. The ApoE À/À single knockout (SK) mice used in the following experiment were also derived from the firstgeneration heterozygote mice. As a result of the crossbreeding, the breeding pairs for DK and SK mice were on a similar genetic background. The genotypes of all mice were verified on tail DNA by PCR, using the methods provided by Dr Saido (for CAST genotyping) and the Jackson Laboratory (for ApoE genotyping). 25 The DK and SK female mice were fed with the Western diet beginning at 5 weeks of age (n ¼ 12). After 10 months on the Western diet, mice were killed and organ tissues were harvested (24-h urine samples were collected in individual mice using metabolic cages before killing). Additional DK and SK female mice (n ¼ 4 each) were fed with normal chow during the course of the experiment to serve as 'normal' controls. To avoid gender as a potential confounding factor, only female mice were used in our studies. All animal studies were approved by the IACUC of Seattle Children's Research Institute.
Biochemical Parameters
Plasma cholesterol levels were measured with a colorimetric assay (Cholesterol/Cholesteroyl Ester Quantitation Kit; BioVision Laboratories, Mountain View, CA, USA). Serum creatinine concentration was determined using the Jaffe reaction method previously established by Butler. 26 Blood urea nitrogen levels were assessed using the Urea Nitrogen Liquid Reagent (Kinetic Method) as per the manufacturer's instructions (TECO Diagnostics, Anaheim, CA, USA). Urinary albumin was measured using the QuantiChrom BCG Albumin Assay Kit (BioAssay Systems, Hayward, CA, USA).
Northern Blotting
Total RNA was isolated from kidneys using Trizol reagent (Invitrogen Corporation, Carlsbad, CA, USA) according to the manufacturer's protocol. Northern blot analyses for aSMA, transforming growth factor-b1 (TGF-b1), MCP-1, and OPN were performed as previously described. 13, 14, 24 Western Blotting and Coimmunoprecipitation Western immunoblotting (IB) and coimmunoprecipitation (IP/IB) experiments were performed following standard protocols. 27 Specifically, calpain-1 was pulled down from 80 mg kidney protein samples in a nonreducing buffer with the monoclonal antibody (15C10) specific for subunit p80. The samples were then separated by a 10% SDS-PAGE in a reducing condition. Blots were probed with the rabbit polyclonal antibody for calpain-1 (domain IV) and labeled with the AlexaFluor680-conjugated secondary antibody (Molecular Probe). For western blot loading controls, blots were probed with the FITC-conjugated anti-b-actin monoclonal antibody. The stained fluorescent intensities were scanned and analyzed with a Typhoon TRIO Variable Mode Imager (Amersham Biosciences).
Histopathology
Paraffin-embedded kidney sections were stained with primary antibodies to nAChRa1, aSMA, type IV collagen, MCP-1, and OPN, and were labeled using a standard ABC kit protocol (Vector Laboratories, Burlingame, CA, USA). Immunofluorescent (IF) staining for F4/80 þ macrophages was performed on frozen renal sections, identified with the FITC-conjugated goat anti-rat IgG secondary antibody (Southern Biotechnology Associates). Sections lacking primary antibodies were run in parallel as negative controls. For nAChRa1-expressing macrophage double stains, F4/80 and nAChRa1 were identified with FITC (green) and AlexaFlour680 (red) fluorescence, respectively. For calpain-1-expressing macrophage double stains, F4/80 and calpain-1 were labeled with AlexFlour680 (red) and FITC (green) nAChRa1 and macrophage calpain-1 activation G Zhang et al fluorescence, respectively. Renal lipid deposition levels were detected by Oil Red O staining as previously described. 28 Tissue calcium levels were measured on paraffin-embedded, Von Kosa stained kidney sections. 29 
Morphometric Analyses
Histological images were captured using a SPOT digital camera, and the stained areas were quantified using the Image-Pro Plus software as we previously described (Media Cybernetics, Silver Spring, MD, USA).
14,30 For immunohistology (aSMA, F4/80, MCP-1, OPN, and type IV collagen), the staining in glomeruli and tubulointerstitium were evaluated separately. The results were expressed as a positive percentage of each area of interest (glomeruli or tubulointerstitium). Disruption of glomerular and tubular basement membranes (GBM/TBM) was evaluated by measuring the staining intensities of the type IV collagen component of the GBM/TBM in combination with the disappearance of a typical loop structure. For this purpose, a specific color intensity threshold derived from the type IV collagen staining on baseline or 'normal' kidneys was first defined by the software as a strong staining (representing the intact basement membrane component). Only the strongly stained areas were counted as positive in terms of the integrity of the GBM/TBM. For the Oil Red O and Von Kosa stains, the staining was not separately quantified by glomeruli and tubulointerstitium because of the small areas of positivity; and the results were expressed as a positive percentage of the renal section area.
Statistical Analyses
Data were analyzed using the Student's t-test (parametric data) or Mann-Whitney U-test (nonparametric data), and the null hypothesis rejected at a P-value o0.05 unless specified elsewhere. Results are presented as mean ± 1 s.d. unless stated otherwise.
RESULTS
The nAChRa1 Regulates Calpain-1 Activation in Kidneys of ApoE À/À Mice and in Mononuclear Cell Culture In baseline kidneys (2 months on Western diet, before DNA injection/uninephrectomy), renal nAChRa1 was barely detectable by western blotting in the ApoE À/À mice ( Figure 1 ). After 6 months on a high fat diet, after DNA injection/uninephrectomy, the nAChRa1 protein expression was strongly and significantly upregulated in the kidneys of the control pscr-treated ApoE À/À mice. With gene silencing, the renal nAChRa1 expression was suppressed by 70% (psir2 versus pscr, n ¼ 8 per group, Po0.05). By immunolocalization (Figure 1 ), the nAChRa1 protein was mainly found in the diseased glomeruli and on tubulointerstitial cells. As illustrated by double IF staining, the majority of nAChRa1-expressing glomerular cells was identified as some F4/80 þ infiltrated macrophages.
The tissue calcium deposition levels were evaluated by a Von Kosa staining because the cell receptor nAChRa1 can function as a calcium channel, and changes in intracellular calcium concentration even though at micromol levels can regulate calpain-1 activation. Renal calcium levels were elevated to fivefold after 6 months of Western diet in the pscrtreated mice (0.75±0.6 versus 3.5±1.1%, at 6 months versus baseline, n ¼ 6, Po0.05). The nAChRa1-interference reduced the calcium level in the diseased kidneys by more than fourfold (0.79 ± 0.6 versus 3.5 ± 1.1%, psir2 versus pscr, n ¼ 6, Po0.05). The level of renal calpain-1 activity increased 10-fold compared with baseline levels in the pscr-treated mice (6 months versus baseline, n ¼ 8, Po0.05) (Figure 2a) . The knockdown of the nAChRa1 for 4 months was associated with a 70% reduction in the active calpain-1 (58 kDa) level in the kidneys of the psir2-treated mice (psir2 versus pscr, n ¼ 8, Po0.05) (Figure 2a) . No difference was found in renal activated calpain-2 protein in the psir2-treated compared with the pscr-treated mice (data not shown), despite significantly different calpain-2 activities found in monocyte cultures (Figure 2b ). By immunohistochemistry, renal calpain-1 protein was expressed by glomerular and interstitial cells in the pscr-treated mice, but almost undetectable in the psir2-treated mice (Figure 2a) .
In vitro the nAChRa1 was expressed by the mouse monocyte cell line WEHI-274.1. Silencing nAChRa1 expression on the cells significantly reduced the activities of both calpain-1 (60% decrease) and calpain-2 (90% decrease), and reduced the cleaving of calpain substrate talin by 20% (psir2 versus pscr, n ¼ 4, all Po0.05) (Figure 2b ). These results suggest that the receptor nAChRa1 is an important upstream regulator of the calcium-dependent activation of calpain-1 in the hypercholesterolemic model of CKD.
Renal Macrophage Inflammation is Reduced in the nAChRa1-Silenced Mice F4/80 þ renal monocytes/macrophages, the dominant inflammatory cell type during hypercholesterolemic nephropathy, were significantly increased over time in the pscr-treated mice (Figure 3a) . The numbers of F4/80 þ cells were 2-and 10-fold elevated in the glomeruli and cortical tubolointerstitium, respectively, in the kidneys of the pscrtreated ApoE À/À mice (6 months versus baseline, n ¼ 6, Po0.05). The nAChRa1 knockdown by the psir2 treatment prevented the increase of macrophage infiltration in both the glomerular and tubulointerstitial compartments (6 months versus baseline, n ¼ 6, P40.05). The depressed macrophage recruitment was coupled with reduced expression of two important monocyte chemoattractant chemokine genes: the MCP-1 and OPN. The baseline renal levels of MCP-1 and OPN mRNA and protein were minimal; expression was limited to the vascular walls and the interstitial macrophagelike cells (Figure 3b ). In the pscr-treated mice, the mRNA and protein expression of the two chemokines significantly increased by three-to fivefold in all compartments of the nAChRa1 and macrophage calpain-1 activation G Zhang et al kidney (6 months versus baseline, n ¼ 5, all Po0.05). In the nAChRa1-silenced mice, MCP-1 and OPN mRNA and protein levels remained very low at 6 months after being fed with Western diet (6 months versus baseline, n ¼ 5, mRNA or protein, all P40.05). These finding suggest that the activation of receptor nAChRa1 is strongly associated with the regulation of macrophage recruitment in the model of hypercholesterolemic nephropathy. nAChRa1
Early Profibrotic Renal Response is Blunted in the nAChRa1-Silenced Kidney
The hyperlipidemic nephropathy was characterized by a profibrotic renal response with upregulation of TGF-b mRNA (sixfold) in the pscr-treated mice (6 months versus baseline, n ¼ 5, Po0.05) (Figure 4) . The renal TGF-b1 mRNA level was 50% lower in the nAChRa1-silenced mice compared with the pscr-treated mice (n ¼ 5, Po0.05) ( Figure  4a ). In baseline kidneys, no aSMA staining was found in glomerular tufts or tubulointerstitium except in the smooth muscle of vascular walls (Figure 4b ). In the pscr-treated group, there was a strong de novo presentation of the aSMA þ myofibroblasts in both the glomeruli and tubulointerstitium after 6 months on Western diet. In the psir2-treated group, a small amount of glomerular aSMA þ staining was seen in the glomeruli and no tubulointerstitial myofibroblast was observed. As quantified by western blot analyses (Figure 3) , the aSMA protein levels of the psir2-treated group were reduced by 90% when compared with the pscr-treated group (n ¼ 6, Po0.05). Northern blot analyses showed 50% reduced aSMA mRNA levels in the psir2-treated mice compared with the pscr-treated mice (n ¼ 5, Po0.05).
Less Severe Basement Membrane Damage and Better Renal Functions in the nAChRa1-Silenced Mice
The chronic inflammatory-fibrotic responses in this hypercholesterolemic CKD model led to a destructive process that was characterized by the damage of vascular, GBM/TBM, renal lipid deposition, and functional loss ( Figure 5 ). As illustrated in Figure 5a , the baseline kidney demonstrated nAChRa1 and macrophage calpain-1 activation G Zhang et al intensive collagen type IV staining of the basement membrane structures with intact capillary loops in the glomerular tufts/peritubular areas, and morphologically normal tubules. By 6 months, the area of the kidney occupied by the main basement membrane component collagen type IV was greatly reduced in the pscr-treated mice (three-to fivefold lower, 6 months versus baseline, n ¼ 6, Po0.05). The regular capillary loop structure appeared to be damaged and distorted, and some renal tubules were dilated. The collagen type IV component was significantly less damaged in the kidneys of the psir2-treated mice (two-to threefold higher, psir2 versus pscr, n ¼ 6, Po0.05), resulting in a better morphology of the kidneys (Figure 5a ). Renal lipid deposition, as measured by Oil Red O staining, was minimal at the baseline (Figure 5b) . By 6 months, the Oil Red O stain-positive area was greatly increased by 15-fold in the kidneys of pscr-treated mice (6 months versus baseline, n ¼ 6, Po0.05). The lipid uptake and deposition in glomerular and tubulointerstitial tissues was significantly reduced in the nAChRa1-silenced mice (98% lower, psir2 versus pscr, n ¼ 6, Po0.05), despite similar serum cholesterol levels (569.1±26.2 versus 549.4±12.4 mg per 100 ml, psir2 nAChRa1 and macrophage calpain-1 activation G Zhang et al versus pscr, n ¼ 5, P40.05). In association with less severe renal pathological changes, the kidney function was better preserved in the psir2-treated mice (serum creatinine (SCr), 1.95 ± 0.5 versus 3.2 ± 0.7 mg per 100 ml, psir2 versus pscr, n ¼ 5, Po0.05).
Increased Endogenous Calpain Activity Promotes Renal Macrophage Inflammation in the CAST
À/À ApoE À/À Mice In the absence of calpastatin (the only known endogenous calpain inhibitor), renal levels of the activated calpain-1 were fivefold higher in the CAST À/À ApoE À/À (DK) mice compared with the ApoE À/À (SK) mice even on normal diet (n ¼ 4, Po0.05) (Figure 6a ). Maintained on a Western diet for 10 months, the renal calpain-1 activation was significantly augmented by three-and eightfold in the DK and SK mice, respectively (Western diet versus normal diet, n ¼ 4, both Po0.05). The serum or kidney levels of the activated calpain-1 were about twofold higher in the DK mice compared with the SK mice (n ¼ 4, both Po0.05) 10 months on Western diet (Figure 6a) . The integrin-to-cytoskeleton anchorage protein talin (a calpain substrate that is thought to be involved in the activation and migration of CD11b þ leukocytes/macrophages) 31 was abundantly expressed-both the intact (225 kDa) and the calpain-cleaved (190 kDa) forms-in the kidneys of the SK mice on normal diet (Figure 6b ). In the DK mice, all talin protein detected by western blot was in the calpain-cleaved form and in a significantly smaller quantity (77% decrease, DK versus SK, n ¼ 4, normal diet). The talin protein was completely cleaved and degraded to a barely detectable level in both the DK and SK mice 10 months after being fed with Western diet. nAChRa1 and macrophage calpain-1 activation G Zhang et al F4/80 þ macrophages were rarely seen in the glomeruli and tubulointerstitium of the SK mice that were fed a normal diet (at the age of 11 months). F4/80 þ cells were increased in the glomeruli and tubulointerstitium of the same-aged mice that had been on the Western diet for 10 months (Figure 7a) . Associated with calpain-1 overactivity in the DK mice, a significantly higher baseline number of the F4/80 þ macrophages was present in kidneys of the DK mice on normal diet (threefold higher, DK versus SK, n ¼ 4, Po0.05). Renal macrophages recruitment was enhanced by the Western diet in the DK mice (17-and 8-fold increases, in the glomeruli and tubulointerstitium, respectively, Western diet (n ¼ 6) versus normal diet (n ¼ 4), both Po0.05). This resulted in a significantly greater F4/80 þ macrophage infiltration of the kidneys of the DK mice compared with the SK mice on the Western diet (10-and 3-fold higher, in the glomeruli and tubulointerstitium, respectively, n ¼ 6, both Po0.05) (Figure 7a) . The difference in the degrees of the renal inflammatory response following the Western diet was further confirmed by western analysis of the leukocyte/ macrophage marker CD11b (2.6-fold higher in the DK mice versus SK mice, n ¼ 4, Po0.05) (Supplementary Figure 1) . As illustrated by IF double staining of a hypercholesterolemic DK kidney, all F4/80 þ macrophages strongly expressed calpain-1 protein, and were the main source of calpain-1 in the inflamed kidney (Figure 7b ).
Calpain Hyperactivity Leads to More Severe Inflammatory Destruction and Renal Functional Loss
Intact GBM/TBM structures were clearly demonstrated in baseline kidneys, with no differences in the percentage area of collagen type IV staining between the DK and SK mice. Additional collagen type IV-positive staining appeared in the interstitial compartments in between the basement membrane structures (GBM/TBM) in the Western diet group of SK mice (Figure 8a) , perhaps a manifestation of the fibrotic response of the model. This resulted in a slightly increased collagen type IV-stained area in the SK mice fed on Western diet (1.5-fold increase, Western diet versus normal diet, n ¼ 4, Po0.05). In contrast, the type IV collagen component of the GBM and TBM was significantly reduced by about 70 and 50%, respectively, in the Western diet group of DK mice nAChRa1 and macrophage calpain-1 activation G Zhang et al (Western diet (n ¼ 6) versus normal diet (n ¼ 4), both Po0.05). The more severe GBM/TBM damage in the DK mice coincided with a stronger aSMA þ myofibroblast response incited by the Western diet (Figure 8b) . The de novo appearance of glomerular aSMA þ myofibroblasts was fourfold higher in the DK mice when fed with the Western diet (DK versus SK, n ¼ 6, Po0.05). Tubulointerstitial aSMA þ area was also fivefold higher in the DK mice, but did not reach statistical significance (DK versus SK, n ¼ 6, P ¼ 0.06). These data suggest that calpain-1 hyperactivity promotes renal inflammatory-fibrotic cellular responses and GBM/TBM damage in the hypercholesterolemic mice.
In terms of clinical parameters, serum cholesterol levels were above 1000 mg per 100 ml, but similar in the DK and SK Figure 4 Reduced renal TGF-b1 mRNA and aSMA þ myofibroblasts by nAChRa1 silencing. (a) Kidney Northern blot analysis illustrates a significant twofold reduction in aSMA or TGF-b1 mRNA because of nAChRa1 silencing seen in the psir2-treated hyperlipidemic CKD mice, but not in the pscr-treated mice. The histogram represents semiquantitative results (mean ± s.d.) of Northern blot analysis. The GAPDH mRNA bands were used to correct for RNA loading. # Po0.05, pscr versus baseline, *Po0.05, psir2 versus pscr, n ¼ 5. (b) aSMA IHC photomicrographs illustrate that aSMA þ myofibroblasts were absent in both the glomeruli and interstitium (excluding vascular smooth muscle) of the baseline kidneys. De novo expression of aSMA was observed in both glomerular and interstitial compartments 6 months after Western diet, but to a notably milder extent in the nAChRa1-silenced mice. Original magnification: Â 400. Renal aSMA western blot analysis illustrates a significant 90% reduction in total aSMA protein in the psir2-treated mice compared with the pscr-treated mice (*Po0.05, n ¼ 6). The b-actin bands were used to correct for protein loading. The histogram represents mean band densities.
nAChRa1 and macrophage calpain-1 activation G Zhang et al mice after 10 months on a Western diet ( Table 1 ). The 24-h urine albumin was 3.5-fold higher in the DK mice (DK versus SK, n ¼ 8, Po0.05), consistent with the pathological changes. Kidney function, as measured by SCr and blood urea nitrogen levels, was diminished to a greater extent in the DK mice (DK versus SK, n ¼ 8, both Po0.05) ( Table 1) .
DISCUSSION
Hyperlipidemia is thought to accelerate the progression of kidney disease, but the mechanisms by which hyperlipidemia exerts its deleterious effect remains largely unclear. 3, 4, 32 This study specifically addresses the role of the muscle type nicotinic receptor, nAChRa1, on the progression of hypercholesterolemic nephropathy. Long-term in vivo knockdown of the nAChRa1 gene is renoprotective in the mouse model of hypercholesterolemic CKD. The results suggest that nAChRa1 mediates the progressive nephropathic inflammatory response by functioning as a regulator of calpain-1 activation. This study has suggested that the nAChRa1-calpain-1 activation intracellular conduit is involved as a novel proinflammatory pathway in the hypercholesterolemiainduced CKD. The nAChR family has been shown to serve as a ligandgated ion channel capable of mediating a variety of physiological activities. They are made up of a group diverse isoforms, each consisting of the specific assembly of five polypeptide subunits (the a1-10, b1-4, g, d, and e) in either a homomeric or heteromeric configuration. [33] [34] [35] Although the muscle-type nAChR ((a1) 2 b1gd/e) was originally discovered at neuromuscular junctions, it has since been identified in a variety of other cell types ranging from endothelial cells, vascular smooth muscle cells, immune cells, fibroblasts, and cancer cells. 36 We have recently identified the nAChRa1 as an alternative uPA receptor. It is evident that the distinct structural components of individual nAChR isoforms directly relate to the physiological activity that the receptor regulates. For instance, it is now widely accepted that the nAChRa7 has an antiinflammatory role; it is expressed by tubular cells in the kidney ischemia/reperfusion injury model, and is renoprotective. 37 We recently reported that the nAChRa1 isoform promotes renal fibrosis through a mechanism that involves myofibroblast phenotypic regulation. 14 In the obstructive fibrotic kidney, the uPA rather than acetylcholine may be the dominant endogenous ligand for interstitial nAChRa1.
Dyslipidemia is considered as a common factor contributing to the severity of renal function loss in patients with 38 The ApoE À/À mouse model of hyperlipidemic nephropathy has been well characterized and widely used for mechanistic and interventional studies. 3, 4, 30, 39 Hyperlipidemia is thought to promote chronic macrophage inflammation associated with significant renal-damaging effects in this model. In this study, we report that nAChRa1 expression is increased in both glomerular and interstitial cells including macrophages, and suggest that downstream calpain-1 activation promotes renal inflammation and chronic kidney injury. The silencing of nAChRa1 gene was associated with a considerable reduction in renal calpain-1 activation levels. The downstream reduction in calpain-1 activity led to a less severe renal inflammatory response, as suggested by our findings in mice with genetically induced calpain-1 overactivity because of the deficiency in the endogenous calpain inhibitor calpastatin. Calpain hyperactivity promoted 10-fold higher renal F4/80 þ macrophage infiltration in the CAST À/À ApoE À/À mice, leading to significantly increased aSMA þ myofibroblasts, increased GBM/TBM destruction, and extensive kidney function loss ( Figure 9 ).
Calpains are intracellular calcium-activated, nonlysosomal cysteine proteases that cleave cytoskeletal and submembranous proteins. The calpain system consists of two ubiquitous forms of calpain (calpain-1 or m-calapin and calpain-2 or m-calpain), a tissue specific calpain (n-calpain), and a single known endogenous calpain inhibitor (calpastatin). Calpains participate in a variety of cellular functions, including regulation of cytoskeletal structures, cell-cycle progression, and cell spreading, adhesion and migration. [40] [41] [42] [43] For instance, with the use of in vivo experiments McDonald et al 44 and Chatterjee et al 45 showed that the calpain inhibitor, N-acetyl-Leu-Leu-norleucinal, protected multiple organs from failure following hemorrhagic shock and reduced renal injury induced by ischemia/reperfusion. We have further addressed in this study that renal calpain-1 activation is, at least in part, regulated by the nAChRa1 receptor, which promotes the macrophage inflammation and disease progression in the experimental model of hypercholesterolemic CKD. The changes in calpain-1 activity, either downregulated by nAChRa1 silencing, or upregulated by calpastatin deficiency, respectively improved or intensified the macrophage inflammatory response and overall kidney damage. Previous studies suggest that calpain-1 regulates the inflammatory response by promoting inflammatory cell migration and proinflammatory cytokines production. [18] [19] [20] Cell migration is a dynamic process that requires temporal and spatial regulation of integrin activation and focal adhesion assembly/ disassembly. Talin is an actin and integrin tail-binding protein found in variety of tissues and cell types. Proteolysis of talin by calpain is essential for integrin activation, including leukocyte/macrophage CD11b/CD18 liberation and focal adhesion formation. 30 Calpain-1 is also vitally involved in endocytosis; 46 the cellular process macrophages and other types of cells use to uptake lipids.
Myofibroblasts are characterized as fibroblasts that have acquired myocyte characteristics such as contractile properties and aSMA expression. They are thought to be the primary source of the scar-forming extracellular matrix proteins in many solid organs, including kidneys. The density of glomerular or interstitial myofibroblasts is highly correlated with the decline of kidney functions in patients with Figure 9 Schematic summary of the nAChRa1-calpain pathways involved in hypercholesterolemic CKD. The muscle-type nicotinic receptor (nAChRa1) has two known endogenous ligands: the uPA and acetylcholine. On ligation the receptor transforms into a calcium channel, which subsequently activates the intracellular calcium-dependent cysteine protease calpain-1. The activated calpain-1 promotes cell motility, perhaps by cleaving cytoskeleton-integrin linking proteins such as talin and liberating cell surface integrins (eg, CD11b/CD18). Calpain-1 hyperactivity significantly accelerates renal macrophage recruitment in the mouse model of hypercholesterolemic CKD. The persistently accumulated renal macrophages, through autocrine or interactions with kidney-resident cells (paracrine), produce various destructive molecules such as chemokines (eg, MCP-1 and OPN), cytokines (eg, TGF-b), and metalloproteinases (eg, MMP-2 and MMP-9). These molecules further enhance renal inflammation, degrade the collagen components of GBM/TBM, and promote the matrix-producing myofibroblasts by transforming mesangial cells and pericytes, or by activating interstitial fibroblasts. The nAChRa1-regulated calpain-1 activity may also be involved in the lipid-uptake process by macrophages and kidney-resident cells. These destructive events ultimately lead to significant clinical proteinuria and kidney function loss. MCP-1, macrophage chemoattractant protein-1; OPN, osteopontin; TGF-b, transforming growth factor-b; MMP, metalloproteinase; SCr, serum creatinine; BUN, blood urea nitrogen; GBM/TBM, glomerular and tubular basement membranes.
nAChRa1 and macrophage calpain-1 activation G Zhang et al CKD. 47 The de novo appearance of glomerular aSMA þ cells is thought to be due to a transformation of activated mesangial cells. 48 Interstitial myofibroblasts are derived from either activated peritubular/perivascular fibroblasts, or transformed pericytes and tubular epithelial cells. 30 Pericytes are considered tissue-specific mesenchymal stem cells, with the potential to transdifferentiate into other functional mesenchymal cell types, such as the collagen-synthesizing myofibroblasts. 49 It has been argued recently, by a fate-tracing study, 50 that pericytes and perivascular fibroblasts rather than epithelial cells are the primary source of myofibroblasts in kidney fibrosis. The molecular basis of renal myofibroblast accumulation remains poorly understood. Growth factors such as TGF-b and members of the urokinase system have been shown to participate. 8, 47 Disruption of the basement membrane is a key step in initiating the transformative process of glomerular or interstitial cells. 51 This study has shown that cellular receptor nAChRa1 and its downstream activation of calpain-1 may be implicated in promoting the myofibroblast phenotypic transformation directly or indirectly, through TGFb production and/or basement membrane destruction. 24, 30, 51 Overall, the study demonstrates a unique relationship between the muscle type nicotinic receptor, nAChRa1, and the downstream activation of calpain-1 on the development of the hypercholesterolemia-induced nephropathic inflammatory response. Developing a more thorough understanding of the inflammatory-promoting mechanism by which the nAchRa1-calpain-1 activation conduit acts will better our understanding of CKD, and could lead to more targeted anti-inflammatory pharmaceuticals. In addition, as both the receptor and calpain-1 are involved in other disease pathologies, continued research on this new inflammatorypromoting pathway will be relevant to inflammatory disorders beyond the scope of CKD.
